Characterization of Potential Biomarkers of Eye Disease and Vision Loss.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Eye Disease
- Sponsor
- Association for Innovation and Biomedical Research on Light and Image
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI.
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI
Detailed Description
This is a registry study. Only patients followed under the clinical practice at AIBILI Clinical Trial Centre, and with a signed informed consent form will be included. Based on the clinical information collected under the clinical practice, and based on patients' characteristics, scientific questions will be raised and data will be collected and analysed accordingly. Any procedure performed under clinical practice that may allow for the characterization of the disease and/or for the identification of potential biomarkers will be collected and analysed.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Any patient followed under the normal clinical practice at AIBILI Clinical Trial Centre, and with a AIBILI signed informed consent form for data collection, Imp. 11-7-2 "Consentimento Informado para tratamento de dados".
- •Exclusion criteria:
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI.
Time Frame: 10 years